Acutus Medical, Inc. (AFIB)
USD 0.04
(-4.76%)
USD 0.04
(-4.76%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 53.96 Million USD | -59.56% |
| 2022 | 133.44 Million USD | -21.41% |
| 2021 | 169.79 Million USD | -11.81% |
| 2020 | 192.53 Million USD | 82.58% |
| 2019 | 105.45 Million USD | 306.41% |
| 2018 | 25.94 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 41.66 Million USD | -22.78% |
| 2024 Q2 | 35.47 Million USD | -14.87% |
| 2023 Q3 | 84.72 Million USD | -15.52% |
| 2023 FY | 53.96 Million USD | -59.56% |
| 2023 Q4 | 53.96 Million USD | -36.31% |
| 2023 Q2 | 100.29 Million USD | -13.54% |
| 2023 Q1 | 115.99 Million USD | -13.07% |
| 2022 Q3 | 114.62 Million USD | -17.14% |
| 2022 Q2 | 138.33 Million USD | 5.08% |
| 2022 Q1 | 131.64 Million USD | -22.47% |
| 2022 FY | 133.44 Million USD | -21.41% |
| 2022 Q4 | 133.44 Million USD | 16.41% |
| 2021 Q2 | 140.59 Million USD | -13.19% |
| 2021 FY | 169.79 Million USD | -11.81% |
| 2021 Q1 | 161.94 Million USD | -15.89% |
| 2021 Q4 | 169.79 Million USD | -14.0% |
| 2021 Q3 | 197.42 Million USD | 40.42% |
| 2020 Q2 | 72.02 Million USD | -17.31% |
| 2020 FY | 192.53 Million USD | 82.58% |
| 2020 Q1 | 87.1 Million USD | -17.4% |
| 2020 Q4 | 192.53 Million USD | -9.4% |
| 2020 Q3 | 212.5 Million USD | 195.03% |
| 2019 FY | 105.45 Million USD | 306.41% |
| 2019 Q4 | 105.45 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 25.94 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -72.033% |
| BrainsWay Ltd. | 62.97 Million USD | 14.311% |
| Cerus Corporation | 197.74 Million USD | 72.713% |
| Envoy Medical, Inc. | 7.64 Million USD | -606.283% |
| electroCore, Inc. | 16.38 Million USD | -229.285% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -601.508% |
| IceCure Medical Ltd | 16.41 Million USD | -228.824% |
| Inogen, Inc. | 326.19 Million USD | 83.458% |
| OrthoPediatrics Corp. | 449.58 Million USD | 87.998% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -97.873% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -225.472% |
| MaxCyte, Inc. | 268.27 Million USD | 79.886% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -566.394% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1385.717% |
| Orthofix Medical Inc. | 925.31 Million USD | 94.168% |
| PAVmed Inc | 33.11 Million USD | -62.928% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 62.385% |
| RxSight, Inc. | 182.55 Million USD | 70.441% |
| Sight Sciences, Inc. | 166.65 Million USD | 67.621% |
| SI-BONE, Inc. | 230.42 Million USD | 76.582% |
| TELA Bio, Inc. | 78.04 Million USD | 30.863% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 78.579% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -402.889% |
| Talis Biomedical Corporation | 98.34 Million USD | 45.129% |
| Spectral AI, Inc. | 10.69 Million USD | -404.676% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 75.321% |
| CVRx, Inc. | 115.22 Million USD | 53.172% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 8.014% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1632.123% |
| Bioventus Inc. | 810.91 Million USD | 93.346% |
| Venus Concept Inc. | 93.65 Million USD | 42.384% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -109.757% |
| LivaNova PLC | 2.42 Billion USD | 97.779% |
| 908 Devices Inc. | 202.98 Million USD | 73.416% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 93.299% |
| Nemaura Medical Inc. | 14.56 Million USD | -270.522% |
| NeuroPace, Inc. | 107.65 Million USD | 49.875% |
| LENSAR, Inc. | 69.58 Million USD | 22.455% |
| Apyx Medical Corporation | 79.24 Million USD | 31.903% |
| Cutera, Inc. | 346.29 Million USD | 84.418% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -28.427% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2901.112% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 80.061% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -26.486% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.573% |
| Axonics, Inc. | 719.92 Million USD | 92.505% |
| Outset Medical, Inc. | 313.8 Million USD | 82.804% |
| IRIDEX Corporation | 34.43 Million USD | -56.696% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 86.667% |
| IRadimed Corporation | 92.15 Million USD | 41.447% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -927.027% |
| INVO Bioscience, Inc. | 20.88 Million USD | -158.333% |
| Telesis Bio, Inc. | 70.41 Million USD | 23.364% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 64.984% |
| Varex Imaging Corporation | 1.24 Billion USD | 95.682% |
| Quipt Home Medical Corp. | 247.4 Million USD | 78.19% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -479.592% |
| Pulmonx Corporation | 178.95 Million USD | 69.846% |
| Dynatronics Corporation | 25.94 Million USD | -108.014% |
| Modular Medical, Inc. | 13.8 Million USD | -290.816% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -403.03% |
| Semler Scientific, Inc. | 78.06 Million USD | 30.878% |
| InMode Ltd. | 863.28 Million USD | 93.749% |
| Bruker Corporation | 4.24 Billion USD | 98.73% |
| Cytosorbents Corporation | 53.26 Million USD | -1.313% |
| DexCom, Inc. | 6.26 Billion USD | 99.139% |
| Align Technology, Inc. | 6.08 Billion USD | 99.113% |
| Viveve Medical, Inc. | 25.91 Million USD | -108.235% |
| ZimVie Inc. | 1.2 Billion USD | 95.523% |
| Movano Inc. | 9.42 Million USD | -472.763% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 89.157% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1385.717% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 8.014% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 94.336% |
| Profound Medical Corp. | 43.68 Million USD | -23.517% |
| Insulet Corporation | 2.58 Billion USD | 97.915% |
| enVVeno Medical Corporation | 48.63 Million USD | -10.949% |
| Surmodics, Inc. | 185.73 Million USD | 70.948% |
| iCAD, Inc. | 41.41 Million USD | -30.282% |
| Nuwellis, Inc. | 9.77 Million USD | -452.303% |
| Biotricity, Inc. | 5.94 Million USD | -808.016% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 87.542% |
| Aethlon Medical, Inc. | 8.24 Million USD | -554.379% |
| InspireMD, Inc. | 47.64 Million USD | -13.259% |
| PAVmed Inc. | 33.11 Million USD | -62.928% |
| BIOLASE, Inc. | 35.1 Million USD | -53.728% |
| Beyond Air, Inc. | 56.96 Million USD | 5.269% |
| FONAR Corporation | 214.24 Million USD | 74.814% |
| AxoGen, Inc. | 196.82 Million USD | 72.585% |
| Vivani Medical, Inc. | 45.79 Million USD | -17.824% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 80.827% |
| Inari Medical, Inc. | 674.23 Million USD | 91.997% |
| UFP Technologies, Inc. | 404.13 Million USD | 86.648% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -130.612% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -467.814% |
| Tenon Medical, Inc. | 6.34 Million USD | -750.433% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -473.615% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 47.939% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.832% |
| Sintx Technologies, Inc. | 15.36 Million USD | -251.188% |
| NanoVibronix, Inc. | 6.67 Million USD | -708.511% |
| Quanterix Corporation | 425.01 Million USD | 87.304% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -479.592% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -0.434% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 96.91% |
| TransMedics Group, Inc. | 706.04 Million USD | 92.357% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 14.609% |
| NeuroMetrix, Inc. | 21.42 Million USD | -151.862% |
| Hyperfine, Inc. | 94.19 Million USD | 42.717% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 79.914% |
| Biomerica, Inc. | 9.25 Million USD | -483.099% |
| Bone Biologics Corporation | 3.73 Million USD | -1343.644% |
| AVITA Medical, Inc. | 144.33 Million USD | 62.616% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1008.343% |
| Silk Road Medical, Inc | 265.3 Million USD | 79.661% |